Option Care Health’s (OPCH) Market Perform Rating Reaffirmed at Citizens Jmp

Option Care Health (NASDAQ:OPCH)‘s stock had its “market perform” rating restated by investment analysts at Citizens Jmp in a research report issued to clients and investors on Wednesday, Benzinga reports.

A number of other research analysts also recently issued reports on the company. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and boosted their price target for the company from $28.00 to $32.05 in a report on Tuesday. UBS Group restated a “buy” rating on shares of Option Care Health in a report on Tuesday, September 22nd. Zacks Research raised Option Care Health from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Truist Financial set a $32.05 price target on shares of Option Care Health in a report on Wednesday. Finally, Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Four equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Hold” and an average price target of $29.70.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $31.00 on Wednesday. The company has a fifty day moving average of $23.78 and a 200 day moving average of $23.55. Option Care Health has a 52 week low of $18.01 and a 52 week high of $36.80. The company has a quick ratio of 0.98, a current ratio of 1.47 and a debt-to-equity ratio of 0.91. The firm has a market capitalization of $4.64 billion, a P/E ratio of 23.33, a P/E/G ratio of 1.35 and a beta of 0.58.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. The company’s revenue was up 1.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. On average, research analysts predict that Option Care Health will post 1.7 earnings per share for the current year.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors have recently added to or reduced their stakes in the company. Harbor Investment Advisory LLC purchased a new position in shares of Option Care Health during the second quarter valued at approximately $48,000. Nykredit A S bought a new position in Option Care Health during the 2nd quarter valued at approximately $56,000. Public Employees Retirement System of Ohio bought a new position in Option Care Health during the 2nd quarter valued at approximately $66,000. KBC Group NV raised its stake in Option Care Health by 22.1% during the first quarter. KBC Group NV now owns 5,453 shares of the company’s stock valued at $147,000 after buying an additional 988 shares during the last quarter. Finally, Summitry LLC bought a new stake in Option Care Health in the first quarter worth $200,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health News Roundup

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: CD&R and McKesson agreed to acquire Option Care Health for $32.05 per share in cash, valuing the company at approximately $5.8 billion including debt. The offer represents a 37% premium to the prior closing price and provides a clear near-term valuation catalyst. CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health
• Positive Sentiment: The stock surged on unusually heavy volume following the buyout announcement. A reported spike in call-option activity, with 5,219 calls purchased versus typical daily volume of 281, reflects strong speculative interest surrounding the transaction. Option Care Health Rockets as CD&R, McKesson Table 37% Premium Bid

Option Care Health Company Profile

Option Care Health, Inc (NASDAQ: OPCH) is a provider of home and alternate-site infusion services in the United States. The company works with patients, physicians, hospitals, health plans and pharmaceutical manufacturers to deliver and manage infusion therapy outside traditional hospital settings, including in patients’ homes, ambulatory infusion suites and other community-based locations.

Its services include the provision and administration of specialty medications and other infusion therapies for conditions such as infections, immune disorders, chronic diseases and nutritional deficiencies.